We divided lung cancer patients into p53 mutant and non-mutant groups, and found that the expression levels of PRIM2 and PCNA were significantly increased in the p53 mutant group (Figure 3A), suggesting that PRIM2 and PCNA expression may be partially regulated by p53. This evidence concerns the gene PRIM2 and lung carcinoma.